How to determine which tests to order, how to interpret them, and how to decide on the right treatment course
EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws
New technologies from diffusion-weighted imaging to ultrasonography are being studied and refined, but much is yet to be understood
EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis
Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention
President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration
By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology
Speak Out Rheum: ACR/EULAR Exchange Program Expands Rheumatology Networks
Three young European rheumatologists share their experience in the 2012 ACR/EULAR international academic exchange program
Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)
EULAR: Identify Arthritis Early, Treat it Effectively
Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.